PT1673370E - Forma cristalina de linezolida - Google Patents

Forma cristalina de linezolida Download PDF

Info

Publication number
PT1673370E
PT1673370E PT03769887T PT03769887T PT1673370E PT 1673370 E PT1673370 E PT 1673370E PT 03769887 T PT03769887 T PT 03769887T PT 03769887 T PT03769887 T PT 03769887T PT 1673370 E PT1673370 E PT 1673370E
Authority
PT
Portugal
Prior art keywords
linezolid
crystalline form
preparation
relates
present
Prior art date
Application number
PT03769887T
Other languages
English (en)
Inventor
Dodda Mohan Rao
Pingili Krishna Reddy
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1673370(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Publication of PT1673370E publication Critical patent/PT1673370E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
PT03769887T 2003-10-16 2003-10-16 Forma cristalina de linezolida PT1673370E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (en) 2003-10-16 2003-10-16 A novel crystalline form of linezolid

Publications (1)

Publication Number Publication Date
PT1673370E true PT1673370E (pt) 2009-11-05

Family

ID=34430675

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03769887T PT1673370E (pt) 2003-10-16 2003-10-16 Forma cristalina de linezolida

Country Status (10)

Country Link
US (4) US7714128B2 (pt)
EP (3) EP2100884A1 (pt)
AT (1) ATE442364T1 (pt)
AU (1) AU2003278592A1 (pt)
DE (2) DE09163348T1 (pt)
DK (1) DK1673370T3 (pt)
ES (3) ES2331001T3 (pt)
HU (1) HUE051230T2 (pt)
PT (1) PT1673370E (pt)
WO (1) WO2005035530A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2100884A1 (en) 2003-10-16 2009-09-16 Symed Labs Limited Crystalline form of linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
EP1745028A2 (en) * 2004-06-29 2007-01-24 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
CA2572054A1 (en) * 2004-06-29 2006-01-12 Teva Pharmaceutical Industries Ltd. Crystalline form iv of linezolid
JP2008530028A (ja) * 2005-02-24 2008-08-07 テバ ファーマシューティカル インダストリーズ リミティド リネゾリッド中間体の調製方法
WO2007018588A1 (en) * 2005-07-20 2007-02-15 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical composition comprising linezolid form iv
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
EP2033960A3 (en) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Linezolid crystalline hydrate form and linezolid salts
US20090093631A1 (en) * 2007-09-06 2009-04-09 Ben-Zion Dolitzky Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
EP2493867A1 (en) 2009-10-28 2012-09-05 Synthon BV Process for making crystalline form a of linezolid
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
US20130137864A1 (en) 2009-12-26 2013-05-30 Jayaraman Venkat Raman Process for the preparation of linezolid
CN103140487A (zh) 2010-08-11 2013-06-05 斯索恩有限公司 制备利奈唑胺的方法
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
WO2012029074A2 (en) 2010-09-02 2012-03-08 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
EP2593440A1 (en) 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
EP2683696A1 (en) 2011-03-09 2014-01-15 Synthon BV Process for making crystalline form a of linezolid
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) * 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
WO2013111048A1 (en) * 2012-01-24 2013-08-01 Jubilant Life Sciences Limited Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) * 2012-06-19 2013-12-27 Symed Labs Limited Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) * 2012-08-10 2016-11-15 Indoco Remedies Limited Pharmaceutical composition of linezolid
EP2917189B1 (en) 2012-11-09 2016-08-17 Synthon BV Process for making linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
IN2013MU03508A (pt) 2013-11-06 2015-07-24 Unimark Remedies Ltd
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
WO2016113751A1 (en) * 2015-01-13 2016-07-21 Nosch Labs Private Limited Process for preparing crystalline linezolid form-iii
WO2018051360A1 (en) * 2016-09-16 2018-03-22 Lee Pharma Limited A novel process for the preparation of crystalline linezolid form-iii
US11517574B2 (en) 2017-11-16 2022-12-06 Persica Pharmaceuticals Ltd. Linezolid formulations
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
WO2023062080A1 (en) 2021-10-12 2023-04-20 Persica Pharmaceuticals Ltd. Low back pain treatment

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
EP0615095B1 (de) 1993-03-11 1997-05-07 Landis & Gyr Technology Innovation AG Brennerregler
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
ATE209193T1 (de) 1996-04-11 2001-12-15 Upjohn Co Verfahren zur herstellung von oxazolidinonen
EP0890791A1 (de) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Steuer- und Regelgerät für einen Brenner
CZ20001613A3 (cs) 1997-11-07 2001-12-12 Pharmacia & Upjohn Company Způsob výroby oxazolidinonů
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) * 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
HUP0302874A2 (hu) 2000-08-14 2003-12-29 Teva Pharmaceutical Industries Ltd. Eljárás risperidon előállítására
EP1365739A1 (en) * 2001-02-05 2003-12-03 Pharmacia & Upjohn Company Composition for rectal delivery of an oxazolidinone antibacterial drug
NZ528996A (en) * 2001-04-20 2006-01-27 Upjohn Co Process to prepare oxazolidinones
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP2100884A1 (en) 2003-10-16 2009-09-16 Symed Labs Limited Crystalline form of linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
CA2572054A1 (en) 2004-06-29 2006-01-12 Teva Pharmaceutical Industries Ltd. Crystalline form iv of linezolid
PL1768967T3 (pl) 2004-07-20 2009-09-30 Symed Labs Ltd Nowe związki pośrednie do wytwarzania linezolidu oraz związki pokrewne

Also Published As

Publication number Publication date
US7718800B2 (en) 2010-05-18
EP1673370B1 (en) 2009-09-09
US20060128703A1 (en) 2006-06-15
EP2902386B1 (en) 2020-04-08
ATE442364T1 (de) 2009-09-15
US20080090824A1 (en) 2008-04-17
DE09163348T1 (de) 2010-01-07
ES2331454T1 (es) 2010-01-05
US20080090820A1 (en) 2008-04-17
EP2100884A1 (en) 2009-09-16
WO2005035530A1 (en) 2005-04-21
AU2003278592A1 (en) 2005-04-27
HUE051230T2 (hu) 2021-03-01
DE60329237D1 (de) 2009-10-22
EP1673370A1 (en) 2006-06-28
DK1673370T3 (da) 2009-12-07
US7732597B2 (en) 2010-06-08
ES2331001T3 (es) 2009-12-18
US7714128B2 (en) 2010-05-11
US20080091011A1 (en) 2008-04-17
US7718799B2 (en) 2010-05-18
EP2902386A1 (en) 2015-08-05
ES2803516T3 (es) 2021-01-27

Similar Documents

Publication Publication Date Title
PT1673370E (pt) Forma cristalina de linezolida
USD580059S1 (en) Fastening device for dental prostheses
LUC00153I2 (pt)
HK1145322A1 (pt)
IL188834A0 (en) Novel vaccine composition
HK1070653A1 (en) Novel crystalline compound
SI1524993T1 (sl) Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
DE60315368D1 (de) Korrektur des Weissabgleichs
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
SG145694A1 (en) Novel compounds
DK1522539T3 (da) Krystallinsk komposition indeholdende excitalopram
HUP0301076A2 (hu) Linezolid II kristályforma és előállítása
WO2005075467A3 (en) Crystalline forms of zolmitriptan
AP1955A (en) Novel crystalline modification of the anhydrate ofboscalid
TW200640886A (en) Crystalline forms of linezolid intermediate
HUP0303942A3 (en) Novel vaccine composition
GB0202901D0 (en) Novel vaccine
GB0203296D0 (en) Novel composition
AU2003239581A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
MXPA06000372A (es) Compuestos de silicio y su uso.
GB0218921D0 (en) Novel vaccine
GB0229808D0 (en) Novel compositions
PT1533305E (pt) Processo para a preparação de valsartan e seus intermediários
DE60212130D1 (en) Carvedilolpolymorph
TW200603801A (en) Novel dialkoxy-imidazopyridines